Medical/Pharmaceuticals

Filling gap in market: VenusP-Valve™ approved by China's NMPA

HANGZHOU, China, July 13, 2022 /PRNewswire/ -- On July 11, 2022, VenusP-ValveTM , Venus Medtech's in-house developed innovative transcatheter pulmonic valve replacement (TPVR) system, was approved byChina's National Medical Products Administration (NMPA) for the treatment of severe pulmonary regur...

2022-07-13 20:26 2298

LIMACORPORATE AND ORTHOFIX MEDICAL ANNOUNCE PARTNERSHIP TO PROVIDE SOLUTION FOR PATIENTS WITH HIGH HIP DISLOCATION FOR THE US MARKET

VILLANOVA, Italy, July 13, 2022 /PRNewswire/ -- Limacorporate S.p.A., a global orthopedic company focused on digital innovation and patient-tailored hardware, and Orthofix Medical Inc, a global medical device company with a spine and orthopedics focus, today announced a licensing partnership for ...

2022-07-13 20:10 2354

Glenmark Pharmaceuticals and SaNOtize Announce Peer Reviewed Publication of Its Phase 3 Clinical Trials on SaNOtize's Novel Nitric Oxide Nasal Spray for COVID-19 in Lancet Journal

MUMBAI, India and VANCOUVER, BC, July 13, 2022 /PRNewswire/ -- Glenmark Pharmaceuticals Limited (Glenmark), an innovation-driven, global pharmaceutical company and SaNOtize Research and Development Corp, today announced thatThe Lancet Regional Health Southeast Asia (TLRHSEA) – peer reviewed, high...

2022-07-13 20:06 2559

Brii Biosciences Appoints Dr. Susannah Cantrell as Chief Business Officer

Strategic executive hire adds to Company's global leadership team and positions the Company for continued growth DURHAM, N.C.and BEIJING, July 13, 2022 /PRNewswire/ -- Brii Biosciences Limited  ("Brii Bio" or the "Company", stock code: 2137.HK) a multi-national...

2022-07-13 19:00 2227

Health2Sync and AstraZeneca Taiwan to Kick off Digital Patient Management Programs for Chronic Kidney Diseases

TAIPEI, July 13, 2022 /PRNewswire/ -- Health2Sync, Asia's leading digital chronic disease management platform, announced today that it is signing a Memorandum of Understanding (MOU) with AstraZeneca Taiwan to provide its first digital solution for chronic kidney disease (CKD) patients inTaiwan. T...

2022-07-13 12:47 1604

Subang Jaya Medical Centre Applauded by Frost & Sullivan for Its Leadership Position in the Malaysian Hospital Industry

SJMC is well positioned to drive the private hospital space into its next growth phase, capturing market share and sustaining its leadership in the coming years. SAN ANTONIO, July 13, 2022 /PRNewswire/ -- Recently, Frost & Sullivan researched the Malaysian hospital industry and, based on its ana...

2022-07-13 12:12 1830

SoniVie Announces successful procedure with TIVUS system on first patient enrolled for REDUCED1 Pilot study

TEL AVIV, Israel, July 13, 2022 /PRNewswire/ -- SoniVie, an Israeli company developing a novel proprietary Therapeutic Intra-Vascular Ultrasound (TIVUS™) System to treat a variety of hypertensive disorders, announced that onMay 30th 2022 the first patient was treated with its Renal Artery Denerva...

2022-07-13 12:00 1871

EVERSANA™ Announces Strategic Partnership with Compai Pharma to Expand Commercialisation Services Across the Asia Pacific Region

CHICAGO and SINGAPORE, July 13, 2022 /PRNewswire/ -- EVERSANA™, a pioneer of next-generation commercial services to the global life sciences industry with its Asian regional headquarters inSingapore and offices across Japan, China and other countries in the area, and Compai Pharma, an enterprisin...

2022-07-13 08:57 1799

GenScript ProBio Signs MOU to Form Strategic Partnership with ACT Therapeutics to Development of New CAR-T Cell Therapies

SEOUL, South Korea, July 12, 2022 /PRNewswire/ -- On the July 12, 2022, GenScript ProBio (Brian Ho-sung Min, CEO), a global CDMO, and ACT Therapeutics (Seogkyoung-Kong, CEO), developing next-generation chimeric antigen receptor (CAR)-T cell therapy platform targeting solid cancer, announced that ...

2022-07-13 08:00 2559

Amaran Biotech Introduces the First Fully-Automated Robotic Aseptic Filling Line in Taiwan During Bio Asia-Taiwan 2022 7/28-7/31

HSINCHU, July 13, 2022 /PRNewswire/ -- Amaran Biotechnology Inc., a subsidiary ofTaiwan's OBI Pharma Inc., today announced that the construction of its fully-automated aseptic filling line and facilities, a first inTaiwan, has been completed. The new facility minimizes the risks of human factors ...

2022-07-13 08:00 3474

Bridge Biotherapeutics to Present Interim Clinical Data from Ongoing Phase 1 Study of BBT-176 at the World Conference of Lung Cancer

* The abstract suggests that BBT-176 has shown its capability of inducing clinical tumor responses in EGFR triple mutation-containing patients * Further exploration of the drug efficacy and safety profiles at RP2D is planned * The abstract is now available on the IASLC 2022 WCLC website SEON...

2022-07-13 06:30 1740

Flat Medical Enters the Vascular Access Medtech Domain with its Newly Acquired MDR Certification and New Medical Advisor

TAIPEI, July 12, 2022 /PRNewswire/ -- Flat Medical Co., Ltd., a MedTech company specializing in safety solutions for anesthesia and critical care procedures, announced that it has received Medical Device Regulation (MDR) certification from its Notified Body, the British Standards Institution (BSI...

2022-07-12 21:08 1766

Discovery Life Sciences Acquires AllCells

CREATES PREMIER GLOBAL PROVIDER OF CRITICAL STARTING MATERIALS AND ANALYTIC SERVICES TO ACCELERATE CELL AND GENE THERAPY APPLICATIONS HUNTSVILLE, Ala. and ALAMEDA, Calif., July 12, 2022 /PRNewswire/ -- Discovery Life Sciences™ (Discovery), the biospecimen and biomarker specialists™, today announ...

2022-07-12 21:00 2889

National Comprehensive Cancer Network Shares New Recommendations for Treating Children with Brain Tumors

Newly-published NCCN Guidelines for Pediatric Central Nervous System Cancers synthesize latest evidence to help care teams ensure children with high-grade gliomas have best possible outcomes; available free at NCCN.org. PLYMOUTH MEETING, Pa., July 12, 2022 /PRNewswire/ -- Today, the National Com...

2022-07-12 20:38 1782

KAZIA LAUNCHES NEW SCIENTIFIC ADVISORY BOARD COMPRISED OF WORLD-LEADING EXPERTS IN BRAIN CANCER

SYDNEY, July 12, 2022 /PRNewswire/ -- Kazia Therapeutics Limited (NASDAQ: KZIA; ASX: KZA), an oncology-focused drug development company, is pleased to announce the launch of its Scientific Advisory Board (SAB). The new SAB consists of four distinguished clinicians and scientists with expertise in...

2022-07-12 20:15 2084

WuXi Vaccines Received First GMP Certificate of QC Potency Lab from Ireland Health Products Regulatory Authority

- The first GMP certificate that WuXi Vaccines has received from the regulatory agency - A critical step for WuXi Vaccines to enable the manufacturing of commercial vaccine products in its Dundalk facility and supplying the global market for a top-10 pharmaceutical company DUNDALK, Ireland, Jul...

2022-07-12 16:00 1469

Spike in Geriatric Population Boosts Bone and Joint Health Ingredients Market

Manufacturers should focus on higher bioavailability ingredients and innovation says, Frost & Sullivan SAN ANTONIO, July 12, 2022 /PRNewswire/ -- The need for higher bioavailability ingredients spurs innovation in the bone and joint health ingredients market, finds Frost & Sullivan's recent anal...

2022-07-12 15:12 1345

iNtRON Confirms Efficacy of CDL200 Against CDI Clinical Isolates

* Shows potent and rapid antibacterial activity against clinical isolates in Europe and Korea both * CDL200,  a novel endolysin pipeline for the treatment of Clostridioides difficile Infection (CDI) * The world's first endolysin in capsule formulation to be administered orally BOSTON and SEO...

2022-07-12 10:06 1468

Biomerics Launches Interventional Medical Plastics Division with Acquisition of Dependable Plastics

SALT LAKE CITY, July 11, 2022 /PRNewswire/ -- Biomerics, the leading vertically integrated medical device contract manufacturer in the interventional device market, announced the acquisition of Dependable Plastics and creation of a new division -- Biomerics Interventional Medical Plastics (IMP) D...

2022-07-11 22:00 2157

U.S. Government Secures 3.2 Million Doses of Novavax COVID-19 Vaccine

* Agreement will provide the first protein-based vaccine option in the U.S., pending FDA Emergency Use Authorization and CDC recommendation GAITHERSBURG, Md. ,July 11, 2022 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-gene...

2022-07-11 20:10 2844
1 ... 222223224225226227228 ... 575